United States · FDA National Drug Code directory
ROPINIROLE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43547-555_9bbec058-00a5-4353-bd58-426ddb0b2020
- Product NDC
- 43547-555
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- ropinirole
- Labeler
- Solco Healthcare US, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220322
- Source listing expiry
- 20261231
Source-listed ingredients
- ROPINIROLE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-555-03) · 43547-555-03
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-555-09) · 43547-555-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →